-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Clearside Biomedical, Inc. quarterly and annual Depreciation history and change rate from 2014 to Q1 2025.
- Clearside Biomedical, Inc. Depreciation for the quarter ending 31 Mar 2025 was $85,000, a 204% increase year-over-year.
- Clearside Biomedical, Inc. annual Depreciation for 2024 was $226,000, a 237% increase from 2023.
- Clearside Biomedical, Inc. annual Depreciation for 2023 was $67,000, a 54% decline from 2022.
- Clearside Biomedical, Inc. annual Depreciation for 2022 was $145,000, a 19% decline from 2021.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)